TruBridge expands partnership with Java Medical Group for rural hospitals

Published 23/09/2025, 14:08
TruBridge expands partnership with Java Medical Group for rural hospitals

MOBILE, Ala. - TruBridge, Inc. (NASDAQ:TBRG), a healthcare technology company with a market capitalization of $321 million and currently considered undervalued according to InvestingPro analysis, announced an agreement with Java Medical Group to implement its technology and services at Russellville Hospital in Alabama. The partnership aims to standardize Java Medical Group’s managed hospitals using TruBridge’s nTrust offering, which includes electronic health records, business office outsourcing, and financial health software.

The collaboration is part of an ongoing relationship where TruBridge works across Java Medical Group’s hospital system to improve workflow and outcomes through EHR optimization initiatives, similar to a recently completed project at Unity Medical Center in Tennessee.

"TruBridge is more than a partner; they’re an extension of our shared passion for strengthening rural hospitals," said Bappa Mukherji, founder and CEO of Java Medical Group, according to the press release.

Shannon Hughes, CFO of Java Medical Group, noted a strong synergy between TruBridge’s mission and their commitment to improving rural healthcare, citing TruBridge’s "tangible, effective solutions."

Chris Fowler, president and CEO of TruBridge, expressed that working with Java Medical Group to support community hospitals creates "both excitement and pride."

TruBridge currently supports over 1,500 clients nationwide with technology, services, and strategic expertise focused on rural and community healthcare providers. Java Medical Group manages rural hospitals across Tennessee, Alabama, Georgia, and New Mexico.

The announcement was made in a press release issued by TruBridge.

In other recent news, Cantor Fitzgerald has reiterated its Overweight rating on TruBridge Inc, maintaining a price target of $29.00. The research firm expressed optimism about the company’s sales pipeline, which appears to be on track for 2025, with several positive signals extending into 2026. These developments suggest confidence in TruBridge’s future performance, according to Cantor Fitzgerald. This analysis is part of recent updates concerning TruBridge’s prospects. Investors may find these insights valuable as they consider the company’s potential growth trajectory. The reiteration of the Overweight rating indicates a positive outlook from the research firm.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.